uniQure Announces Presentations at Upcoming February Conferences
February 06 2017 - 7:00AM
LEXINGTON, Mass. and AMSTERDAM,
the Netherlands, Feb. 06, 2017 (GLOBE NEWSWIRE) -- uniQure N.V.
(NASDAQ:QURE), a leader in human gene therapy, today announced
presentations at the following conferences taking place in
February:
Leerink
Partners 6th Annual Global Healthcare Conference, at the Lotte
New York Palace Hotel in New York City
- Matthew Kapusta, chief executive
officer, will participate in a Fireside Chat on Wednesday, February
15th at 3.00 p.m. EST. The live webcast can be accessed by the
link displayed in the Investor section of the uniQure website
at: http://uniqure.com/investors-newsroom/overview.php. The
webcast replay will be available for at least 72 hours following
the live event.
61st Annual Meeting of Society of Thrombosis and Hemostatis Research at the
Congress Center in Basel, Switzerland
- Professor Wolfgang Miesbach, M.D.
professor of hematology at the University of Frankfurt, Germany and
an investigator in the ongoing Phase 1-2 clinical trial of AMT-060
(AAV5 hFIX) gene transfer in adult patients with severe hemophilia
B, will present previously disclosed interim results from the dose
escalating study on Thursday, February 16th at 15.00 CET/
09.00 a.m. EST.
About
uniQure
uniQure is delivering on the promise of gene therapy - single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with hemophilia, Huntington's disease and cardiovascular
diseases. www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: uniQure N.V. via Globenewswire
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024